The data show that FL-L1CAM and SV-L1CAM mRNAs are both expressed in benign ovarian tumours and both increased during progression of human ovarian carcinomas and were highest in ovarian carcinoma peritoneal metastases (Fig. 1A and B). This evidence concerns the gene L1CAM and ovarian benign neoplasm.